[Immunohematologic follow-up and transfusion safety in hematopoietic stem cells allografts].
Since 1990, specific documentation is established between the immunohematology laboratory of the French EFS Lorraine-Champagne and the marrow transplantation unit of the CHU of Nancy, for patients undergoing hematopoietic stem cells transplantation. These documents and the standardization of the immunohematologic follow-up of those patients, have contributed to the improvement of the transfusion safety.
Mathieu-Nafissi
S
S
Laboratoire d'immunohématologie, établissement français du sang Lorraine-Champagne, avenue de Bourgogne, 54511 cedex, Vandoeuvre-les-Nancy, France. suzanne.mathieu-nafissi@efs.sante.fr <suzanne.mathieu-nafissi@efs.sante.fr>
Janot
C
C
D016913:Blood Component Transfusion; D001787:Blood Group Incompatibility / Q000517:prevention & control; D001788:Blood Grouping and Crossmatching; D003587:Cytomegalovirus / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000517:prevention & control / Q000635:transmission; D005500:Follow-Up Studies; D005568:Forms and Records Control; D005602:France; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006785:Hospitals, University / Q000458:organization & administration; D006801:Humans; D008499:Medical Records; D017751:Safety Management / Q000458:organization & administration*; D014184:Transplantation, Homologous / Q000009:adverse effects